PER
Click for more information
3.80% 7.6¢ percheron therapeutics limited

Charmaine Gittleson Speaks on FDA Feedback, page-2

  1. monti901
    964 Posts.
    lightbulb Created with Sketch. 329
    clock Created with Sketch.
    03/06/21
    15:28
    Post #: 53626204
    Great summary. Charmaine is clear that the FDA is fully supporting this research and allowing fast track of parallel toxicology study reduced from 12 months to 9 months also permitting higher dose. The outcome could not have been better. One more trial before commercialization.. Rerate is imminent.
    Last edited by monti901: 03/06/21
    ANP Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 29  Upvote
    lightbulb Created with Sketch. 5  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
VMT Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢ 		Change
-0.003(3.80%) 		Mkt cap ! $68.51M
Open High Low Value Volume
7.8¢ 7.8¢ 7.5¢ $47.57K 622.6K

Buyers (Bids)

No. Vol. Price($)
1 1598 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 140942 2
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.